Health Autonomy

…with the help of the federal government and universities. Action Alert! The high cost of prescription drugs has recently made headlines, evidenced by price-gouging schemes that cause drug prices to skyrocket 5,000% (as in the case with the infamous Martin Shkreli and the drug Daraprim) or Mylan’s more recent price hike on EpiPen’s to over […]

Help us ensure the supplement form remains available. Action Alert!  Earlier this year, we told you about an FDA back-channel that allows drug companies to turn supplements into drugs—and remove the supplement versions from the market. This has happened to a popular and medically important version of vitamin B6 (pyridoxamine), and with the FDA’s approval […]

The FDA has dialed back a restrictive policy that would severely limit access to individualized natural medicines—but it’s not good enough. Action Alert! The FDA has released a revised draft policy relating to customized, natural medicines made at compounding pharmacies. This revised policy demonstrates that the FDA has listened to ANH members and other stakeholders, […]

If we don’t change a key FDA policy, that’s how much you may be forced to pay if you want to purchase CBD oil. Action Alert! For years, consumers have benefitted from access to cheap, safe, and effective CBD oil supplements. But now the FDA says that CBD is a drug, not a supplement—a drug […]

A new Trump administration rule will allow consumers to better understand the prices for hospital procedures. From the Washington Examiner: Hospitals will be required to post the prices they charge for surgeries and other medical procedures online under a new Trump administration rule… Previously, CMS required that hospitals make the information available to anyone who […]

The FDA is threatening homeopathy’s future. Here’s how we can save it. Action Alert! The FDA has proposed a new policy for regulating homeopathy—a policy which is a direct threat to many, many homeopathic medicines. To fully protect consumer access to these treatments, we need Congress to pass a law. Congress and the FDA have […]

An advisory committee is meeting to make recommendations to the FDA on whether or not to ban certain supplements from being made at specialized pharmacies. On September 12, the FDA’s advisory committee on compounded medicine—medicine made for individual patients at specialized pharmacies—will meet to discuss five ingredients: alpha lipoic acid, CoQ10, creatine monohydrate, pyridoxal 5 phosphate […]